GRPR and prostate carcinoma: Gastrin-releasing peptide (GRP) and its receptor (GRPR) have also been linked to cancerous malignancies [71] and GRPR has been shown to induce the release of IL-8 and vascular growth factor in the case in human prostate cancer cell lines [72].